This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Human Immunodeficiency Virus or Chronic Hepatitis C
and you are
over 18
years old
The phase for this study is not defined.
Show me locations

The purpose

The purpose of this study is to investigate T-cell mediated immune responses to HIV-1 and HCV and determine how these responses are affected by HCV treatment and correlates to response. Furthermore, to study Interferon-inducible protein-10 (IP-10) dynamics during HCV treatment, and correlate this to treatment outcome.

Provided treatments

  • Drug: pegylated interferon-alpha (Pegasys)
  • Drug: ribavirin (COPEGUS)
Tris trial is registered with FDA with number: NCT00909129. The sponsor of the trial is Karolinska Institutet and it is looking for 25 volunteers for the current phase.
Official trial title:
Hepatitis C Virus Dynamic and Immune Activation in HIV-1 Coinfected Patients Treated With Pegylated Interferon Alfa-2a and Ribavirin